Loading…
CIK 0001831942 • 1 13F filing • May 15, 2025 – May 15, 2025
Import this data to Google Sheets with:
=jivedata("commodore-capital-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALKERMES PLC | SHS | $99.3M | 6.6%Prev: 4.5% | 3,550,000 SH | Increased+453,246 SH |
| ALTO NEUROSCIENCE INC | COM SHS | $32.5M | 2.2% | 1,823,196 SH | New |
| AMYLYX PHARMACEUTICALS INC | COM | $68.3M | 4.5%Prev: 2.7% | 5,650,000 SH | Increased+1,574,522 SH |
| ASSEMBLY BIOSCIENCES INC | COM NEW | $34.0M | 2.3%Prev: 1.2% | 1,000,000 SH | Increased |
| ATHIRA PHARMA INC | COM | $3.5M | 0.2% | 464,398 SH | New |
| AVALO THERAPEUTICS INC | COM NEW | $8.8M | 0.6%Prev: 0.3% | 483,000 SH | Increased |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | $1.5M | 0.1%Prev: 1.5% | 18,851 SH | Decreased-481,149 SH |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | $69.7M | 4.6%Prev: 3.8% | 2,565,000 SH | Decreased-463,335 SH |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $25.0M | 1.7%Prev: 3.4% | 1,000,000 SH | Decreased-1,850,000 SH |
| COGENT BIOSCIENCES INC | COM | $78.0M | 5.2%Prev: 5.1% | 2,196,845 SH | Decreased-5,053,155 SH |
| CONTINEUM THERAPEUTICS INC | CL A | $9.3M | 0.6% | 816,326 SH | New |
| CYTOMX THERAPEUTICS INC | COM | $32.8M | 2.2%Prev: 1.2% | 7,692,300 SH | Increased |
| ENLIVEN THERAPEUTICS INC | COM | $72.3M | 4.8%Prev: 4.7% | 4,692,809 SH | Decreased |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $11.1M | 0.7%Prev: 0.4% | 5,397,488 SH | Increased |
| KYMERA THERAPEUTICS INC | COM | $58.4M | 3.9%Prev: 2.1% | 750,000 SH | Increased |
| LB PHARMACEUTICALS INC | COM SHS | $33.4M | 2.2%Prev: 1.2% | 1,500,000 SH | Increased |
| MIND MEDICINE MINDMED INC | COM NEW | $26.8M | 1.8%Prev: 1.9% | 2,000,000 SH | Decreased-1,225,000 SH |
| NURIX THERAPEUTICS INC | COM | $43.2M | 2.9%Prev: 1.7% | 2,275,000 SH | Increased-1,505,055 SH |
| NUVALENT INC | COM | $55.3M | 3.7%Prev: 5.9% | 550,000 SH | Decreased-850,000 SH |
| ORUKA THERAPEUTICS INC | COM | $53.1M | 3.5%Prev: 1.6% | 1,753,054 SH | Increased |
| PALISADE BIO INC | COM | $26.9M | 1.8% | 11,445,000 SH | New |
| PEPGEN INC | COM | $22.1M | 1.5%Prev: 0.5% | 3,400,000 SH | Increased+1,042,681 SH |
| PHARVARIS N V | COM | $52.4M | 3.5%Prev: 2.9% | 1,889,445 SH | Decreased-529,031 SH |
| PROTAGONIST THERAPEUTICS INC | COM | $39.3M | 2.6%Prev: 3.3% | 450,000 SH | Decreased-575,000 SH |
| RAPT THERAPEUTICS INC | COM NEW | $8.5M | 0.6% | 250,000 SH | New |
| RELAY THERAPEUTICS INC | COM | $143.8M | 9.6%Prev: 4.3% | 17,000,000 SH | Increased |
| REPLIMUNE GROUP INC | COM | $13.9M | 0.9% | 1,425,000 SH | New |
| SAB BIOTHERAPEUTICS INC | COM NEW | $16.5M | 1.1%Prev: 0.4% | 4,401,500 SH | Increased |
| SOLENO THERAPEUTICS INC | COM | $55.6M | 3.7%Prev: 4.5% | 1,200,000 SH | Decreased-150,000 SH |
| SPYRE THERAPEUTICS INC | COM NEW | $78.2M | 5.2%Prev: 1.6% | 2,388,245 SH | Increased+400,161 SH |
| TERNS PHARMACEUTICALS INC | COM | $59.6M | 4.0%Prev: 2.1% | 1,475,000 SH | Increased-4,225,000 SH |
| TYRA BIOSCIENCES INC | COM | $88.7M | 5.9%Prev: 2.3% | 3,375,000 SH | Increased |
| XENON PHARMACEUTICALS INC | COM | $80.7M | 5.4%Prev: 5.3% | 1,800,000 SH | Decreased-900,000 SH |
| 13F-HR |
| 0001831942-26-000033 |
| $1.68B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001831942-25-000008 | $1.42B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001831942-26-000025 | $1.73B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001831942-25-000005 | $1.36B | View |